HOME DCVAX ® TECHNOLOGY PRODUCT CANDIDATES CLINICAL TRIALS INVESTORS & MEDIA ABOUT US Press Release 11 DEC 2019 Dr. Bosch’s Presentation at GBM Drug Development Summit in Boston: DCVax®-L Phase III Trial, “Where Are We, And How Did We Get Here?” Click here to download the presentation. Follow us On: DCVAX® TECHNOLOGY About DCVax® Dendritic Cell Immunotherapy Patient Stories & Physician Comments PRODUCT CANDIDATES DCVax® – L DCVax® – Direct DCVax® – Prostate CLINICAL TRIALS Pipeline DCVax® – L Phase III DCVax® – Direct Phase I/II INVESTORS & MEDIA Contacts SEC Filings Stock Information Press Releases Webcasts ABOUT US Overview Company Management Publications Related Links Contact Us © 2017 Northwest Biotherapeutics, Inc. 4800 Montgomery Lane, Suite 800 Bethesda, MD 20814 Phone: 240-497-9024 Forward-looking Statement Legal Disclaimer Privacy Policy

HOME DCVAX ® TECHNOLOGY PRODUCT CANDIDATES CLINICAL TRIALS INVESTORS & MEDIA ABOUT US General Inquiries Full Name* Company Name Email* Contact Purpose Investor related inquiry Media related inquiry Job related inquiry General Subject* Your Message* CAPTCHA Follow us On: DCVAX® TECHNOLOGY About DCVax® Dendritic Cell Immunotherapy Patient Stories & Physician Comments PRODUCT CANDIDATES DCVax® – L DCVax® – Direct DCVax® – Prostate CLINICAL TRIALS Pipeline DCVax® – L Phase III DCVax® – Direct Phase I/II INVESTORS & MEDIA Contacts SEC Filings Stock Information Press Releases Webcasts ABOUT US Overview Company Management Publications Related Links Contact Us © 2017 Northwest Biotherapeutics, Inc. 4800 Montgomery Lane, Suite 800 Bethesda, MD 20814 Phone: 240-497-9024 Forward-looking Statement Legal Disclaimer Privacy Policy

HOME DCVAX ® TECHNOLOGY PRODUCT CANDIDATES CLINICAL TRIALS INVESTORS & MEDIA ABOUT US Notice of Proposed Settlement Stipulation of Settlement.pdf Notice of Settlement.pdf Follow us On: DCVAX® TECHNOLOGY About DCVax® Dendritic Cell Immunotherapy Patient Stories & Physician Comments PRODUCT CANDIDATES DCVax® – L DCVax® – Direct DCVax® – Prostate CLINICAL TRIALS Pipeline DCVax® – L Phase III DCVax® – Direct Phase I/II INVESTORS & MEDIA Contacts SEC Filings Stock Information Press Releases Webcasts ABOUT US Overview Company Management Publications Related Links Contact Us © 2017 Northwest Biotherapeutics, Inc. 4800 Montgomery Lane, Suite 800 Bethesda, MD 20814 Phone: 240-497-9024 Forward-looking Statement Legal Disclaimer Privacy Policy